Clinics in Washington

By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified Sep 22, 2026

What Washington law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Washington at a glance

Pharmacy regulator: Washington Pharmacy Quality Assurance Commission (Washington State Department of Health)
503A framework: Follows the federal 503A framework
Telehealth prescribing: Regulatory: Telehealth allowed
Asynchronous prescribing: Regulatory: Async unclear
Compounded GLP-1 access: Regulatory: Compounded GLP-1 limited

Verified clinics serving Washington

No verified clinics serving Washington are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Washington

Yes. A Washington resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Washington-licensed prescriber, including by telehealth under the Uniform Telehealth Act (chapter 18.134 RCW, enacted 2024), and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the Washington Pharmacy Quality Assurance Commission. Nonresident pharmacies need a Washington license under RCW 18.64.360 backed by an approved inspection report, and every licensee that compounds must follow the USP chapters adopted in WAC 246-945-100. [1] [2] [3] [4] [5] [7]

Compounded GLP-1 access in Washington

Because a nonresident pharmacy that compounds must supply an inspection report from an approved program to keep its Washington license, patients can confirm eligibility through the Department of Health provider credential search. [1] [4] [10]

Research use only sellers in Washington

Chapter 69.41 RCW makes it unlawful to sell, deliver, or possess a legend (prescription) drug except on a valid prescription or as otherwise authorized (RCW 69.41.030), and pharmacy distribution into Washington requires Commission licensure under chapter 18.64 RCW. [3] [6] [11]

Washington notes on specific peptides

BPC-157: Not FDA approved and not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk; a state board cannot authorize what federal law does not. The Pharmacy Quality Assurance Commission has not published a peptide-specific rule. [1] [8] [9]

How to check a clinic in Washington

Confirm the prescribing clinician's license with the Washington medical or nursing board.
Ask which pharmacy compounds or dispenses the peptide and check it in the Washington Pharmacy Quality Assurance Commission (Washington State Department of Health) license lookup. [1] [3] [4] [5] [7]
Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Washington. [3] [6] [11]

Common questions in Washington

Can I get a GLP-1 prescription in Washington through telehealth?

Yes. Under the Uniform Telehealth Act (chapter 18.134 RCW) a Washington-licensed practitioner can establish a relationship with you through telehealth and prescribe under the same standards as an in-person visit. [2]

Does an out-of-state telehealth prescriber need a Washington license?

Generally yes. RCW 18.134.050 requires a Washington license, with narrow exceptions for consultation, specialty assessment, or follow-up care for established patients who are temporarily in Washington. A new GLP-1 patient in Washington needs a Washington-licensed prescriber. [2]

All peptide legal questions for Washington